Loading...
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
BACKGROUND: The role of adjuvant treatment in high-risk muscle-invasive urothelial carcinoma after radical surgery is not clear. METHODS: In a phase 3, multicenter, double-blind, randomized, controlled trial, we assigned patients with muscle-invasive urothelial carcinoma who had undergone radical su...
Saved in:
| Published in: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8215888/ https://ncbi.nlm.nih.gov/pubmed/34077643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2034442 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|